• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子-2α:对辐射敏感性的影响及mTOR抑制剂的差异调节

Hypoxia-inducible factor-2alpha: effect on radiation sensitivity and differential regulation by an mTOR inhibitor.

作者信息

Bhatt Rupal S, Landis Daniel M, Zimmer Michael, Torregrossa Joelle, Chen Shaoyong, Sukhatme Vikas P, Iliopoulos Othon, Balk Steve, Bubley Glenn J

机构信息

Division of Cancer Biology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

出版信息

BJU Int. 2008 Aug;102(3):358-63. doi: 10.1111/j.1464-410X.2008.07558.x. Epub 2008 Apr 3.

DOI:10.1111/j.1464-410X.2008.07558.x
PMID:18394010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4112353/
Abstract

OBJECTIVE

To determine the role of hypoxia-inducible factor-2alpha (HIF2alpha) on the sensitivity of renal cell carcinoma (RCC) cell lines to ionizing radiation and to determine if the mTOR antagonist, rapamycin, could decrease HIF2alpha protein levels.

MATERIALS AND METHODS

Cell lines expressing stable short-hairpin RNAs (shRNAs) encoding HIF2alpha shRNAs or an empty vector were transfected with a hypoxia responsive element (HRE)-driven firefly luciferase reporter gene. Two separate paired cell lines were assayed for their response to increasing doses of ionizing radiation. Proliferation and cell cycle kinetics were compared for cell lines expressing HIF2alpha shRNAs and empty vectors. The effect of an mTOR antagonist, rapamycin on HIF1alpha and HIF2alpha proteins levels was also assessed.

RESULTS

We confirmed that the 786-O RCC lines with stably integrated shRNAs against HIF2alpha had decreased activation of a plasmid with a HRE-driven firefly luciferase reporter gene. Lines from two separate cell clones with decreased HIF2alpha levels showed a significant increase in radiation sensitivity and an increase in G2 cell cycle arrest. Rapamycin, while effective in decreasing HIF1alpha protein levels, did not affect HIF2alpha levels in either of the RCC cell lines.

CONCLUSIONS

These results show that decreasing levels of HIF2alpha leads to an increased sensitivity to ionizing radiation. This finding may explain in part, the known resistance of RCC to radiation therapy. Although mTOR antagonists are approved for the treatment of RCC, these agents do not decrease HIF2alpha levels and therefore might not be effective in enhancing the radio-sensitivity of these tumours.

摘要

目的

确定缺氧诱导因子-2α(HIF2α)在肾细胞癌(RCC)细胞系对电离辐射敏感性中的作用,并确定mTOR拮抗剂雷帕霉素是否能降低HIF2α蛋白水平。

材料与方法

将表达编码HIF2α短发夹RNA(shRNA)或空载体的稳定短发夹RNA的细胞系用缺氧反应元件(HRE)驱动的萤火虫荧光素酶报告基因进行转染。对两个单独的配对细胞系进行检测,以观察它们对递增剂量电离辐射的反应。比较表达HIF2α shRNA的细胞系和空载体细胞系的增殖及细胞周期动力学。还评估了mTOR拮抗剂雷帕霉素对HIF1α和HIF2α蛋白水平的影响。

结果

我们证实,稳定整合有针对HIF2α的shRNA的786-O RCC细胞系,其带有HRE驱动的萤火虫荧光素酶报告基因的质粒激活降低。来自两个HIF2α水平降低的单独细胞克隆的细胞系,其辐射敏感性显著增加,且G2期细胞周期阻滞增加。雷帕霉素虽然能有效降低HIF1α蛋白水平,但对两种RCC细胞系中的HIF2α水平均无影响。

结论

这些结果表明,降低HIF2α水平会导致对电离辐射的敏感性增加。这一发现可能部分解释了RCC对放射治疗已知的抗性。尽管mTOR拮抗剂已被批准用于治疗RCC,但这些药物不会降低HIF2α水平,因此可能无法有效提高这些肿瘤的放射敏感性。

相似文献

1
Hypoxia-inducible factor-2alpha: effect on radiation sensitivity and differential regulation by an mTOR inhibitor.缺氧诱导因子-2α:对辐射敏感性的影响及mTOR抑制剂的差异调节
BJU Int. 2008 Aug;102(3):358-63. doi: 10.1111/j.1464-410X.2008.07558.x. Epub 2008 Apr 3.
2
Reciprocal regulation of hypoxia-inducible factor 2α and GLI1 expression associated with the radioresistance of renal cell carcinoma.缺氧诱导因子 2α 和 GLI1 表达的相互调节与肾细胞癌的放射抵抗相关。
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):942-51. doi: 10.1016/j.ijrobp.2014.06.065. Epub 2014 Oct 18.
3
Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe.同时靶向 mTOR 和 survivin 通过抑制 DNA 损伤修复和放大有丝分裂灾难增强肾细胞癌的放射治疗效果。
J Exp Clin Cancer Res. 2024 Jun 6;43(1):159. doi: 10.1186/s13046-024-03079-8.
4
Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy.评估晚期透明细胞肾细胞癌的合理非交叉耐药联合治疗:联合 mTOR 和 AKT 抑制剂治疗。
Cancer Chemother Pharmacol. 2012 Jan;69(1):185-94. doi: 10.1007/s00280-011-1684-y. Epub 2011 Jun 5.
5
HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.缺氧诱导因子 2α 通过氨基酸载体 SLC7A5 作为 mTORC1 的激活剂。
Mol Cell. 2012 Dec 14;48(5):681-91. doi: 10.1016/j.molcel.2012.09.017. Epub 2012 Oct 25.
6
Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.肾细胞癌中缺氧诱导因子2α的上调与Tsc-2肿瘤抑制基因缺失相关。
Cancer Res. 2003 May 15;63(10):2675-80.
7
Synergistic roles of p53 and HIF1α in human renal cell carcinoma-cell apoptosis responding to the inhibition of mTOR and MDM2 signaling pathways.p53和HIF1α在人肾癌细胞凋亡中对mTOR和MDM2信号通路抑制的协同作用。
Drug Des Devel Ther. 2016 Feb 18;10:745-55. doi: 10.2147/DDDT.S88779. eCollection 2016.
8
PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma.PHGDH作为肾细胞癌HIF2α靶向治疗中丝氨酸生物合成的关键酶
Cancer Res. 2017 Nov 15;77(22):6321-6329. doi: 10.1158/0008-5472.CAN-17-1589. Epub 2017 Sep 26.
9
mTOR in renal cell cancer: modulator of tumor biology and therapeutic target.肾细胞癌中的mTOR:肿瘤生物学的调节因子和治疗靶点。
Expert Rev Mol Diagn. 2009 Apr;9(3):231-41. doi: 10.1586/erm.09.8.
10
The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent.mTOR激酶抑制剂XL388作为一种有前景的抗肾细胞癌药物的临床前评估。
Oncotarget. 2017 May 2;8(18):30151-30161. doi: 10.18632/oncotarget.15620.

引用本文的文献

1
Phase II Study of Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers.镥-奥曲肽治疗进展性转移性嗜铬细胞瘤和副神经节瘤的II期研究:疗效、安全性和生物标志物的中期分析
J Clin Oncol. 2025 Aug 19:JCO2500791. doi: 10.1200/JCO-25-00791.
2
Overcoming the Impact of Hypoxia in Driving Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma.克服缺氧对头颈部鳞状细胞癌放疗抗性的影响
Cancers (Basel). 2022 Aug 26;14(17):4130. doi: 10.3390/cancers14174130.
3
PNJ scaffolds promote microenvironmental regulation of glioblastoma stem-like cell enrichment and radioresistance.

本文引用的文献

1
Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein.簇集素是一种分泌性标志物,用于指示希佩尔-林道肿瘤抑制蛋白的一种不依赖缺氧诱导因子的功能。
Am J Pathol. 2006 Feb;168(2):574-84. doi: 10.2353/ajpath.2006.050867.
2
Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma.Nox4对VHLD肾细胞癌中缺氧诱导因子2-α的转录活性至关重要。
Cancer Res. 2005 Oct 15;65(20):9190-3. doi: 10.1158/0008-5472.CAN-05-2105.
3
The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing.
PNJ 支架促进神经胶质瘤干细胞样细胞富集和放射抗性的微环境调节。
Biomater Sci. 2022 Feb 1;10(3):819-833. doi: 10.1039/d0bm01169j.
4
Interfering with Tumor Hypoxia for Radiotherapy Optimization.干扰肿瘤乏氧以优化放射治疗。
J Exp Clin Cancer Res. 2021 Jun 21;40(1):197. doi: 10.1186/s13046-021-02000-x.
5
ALK-transformed mature T lymphocytes restore early thymus progenitor features.ALK 转化的成熟 T 淋巴细胞恢复早期胸腺祖细胞特征。
J Clin Invest. 2020 Dec 1;130(12):6395-6408. doi: 10.1172/JCI134990.
6
Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma.mTOR 抑制剂依维莫司联合组蛋白去乙酰化酶抑制剂帕比司他治疗晚期透明细胞肾细胞癌的 I 期研究。
Invest New Drugs. 2020 Aug;38(4):1108-1116. doi: 10.1007/s10637-019-00864-7. Epub 2019 Oct 25.
7
HIF-1α and HIF-2α Differently Regulate the Radiation Sensitivity of NSCLC Cells.HIF-1α 和 HIF-2α 对非小细胞肺癌细胞的辐射敏感性有不同的调节作用。
Cells. 2019 Jan 12;8(1):45. doi: 10.3390/cells8010045.
8
Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.肾癌的放射治疗:被忽视方法的复兴。
Nat Rev Urol. 2017 Sep;14(9):549-563. doi: 10.1038/nrurol.2017.87. Epub 2017 Jun 20.
9
Sequence Analysis and Phylogenetic Studies of Hypoxia-Inducible Factor-1α.缺氧诱导因子-1α的序列分析与系统发育研究
Cancer Inform. 2017 May 31;16:1176935117712242. doi: 10.1177/1176935117712242. eCollection 2017.
10
The role of hypoxia-inducible factor-2 in digestive system cancers.缺氧诱导因子-2在消化系统癌症中的作用。
Cell Death Dis. 2015 Jan 15;6(1):e1600. doi: 10.1038/cddis.2014.565.
冯·希佩尔-林道蛋白、低氧诱导因子羟基化与氧感知
Biochem Biophys Res Commun. 2005 Dec 9;338(1):627-38. doi: 10.1016/j.bbrc.2005.08.165. Epub 2005 Aug 30.
4
Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.缺氧诱导因子-1阻断对肿瘤放射敏感性的多效性作用。
Cancer Cell. 2005 Aug;8(2):99-110. doi: 10.1016/j.ccr.2005.06.016.
5
Targeted replacement of hypoxia-inducible factor-1alpha by a hypoxia-inducible factor-2alpha knock-in allele promotes tumor growth.通过缺氧诱导因子-2α敲入等位基因靶向替换缺氧诱导因子-1α可促进肿瘤生长。
Cancer Res. 2005 Mar 15;65(6):2277-86. doi: 10.1158/0008-5472.CAN-04-3246.
6
Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha.通过使用靶向缺氧诱导因子-1α的小干扰RNA增强体外缺氧诱导的肿瘤细胞死亡及体内放射治疗效果。
Cancer Res. 2004 Nov 15;64(22):8139-42. doi: 10.1158/0008-5472.CAN-03-2301.
7
Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.缺氧诱导因子1α的表达可预测IIIB期宫颈鳞状细胞癌单纯放疗后的无转移生存期。
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):513-21. doi: 10.1016/j.ijrobp.2004.03.025.
8
Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.辐射和布洛芬对因冯·希佩尔-林道肿瘤抑制基因功能丧失而过度表达缺氧诱导因子的常氧肾癌细胞的影响。
Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4158-64. doi: 10.1158/1078-0432.CCR-04-0005.
9
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.mTOR抑制通过调节凋亡和HIF-1依赖途径逆转Akt依赖的前列腺上皮内瘤变。
Nat Med. 2004 Jun;10(6):594-601. doi: 10.1038/nm1052. Epub 2004 May 23.
10
Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.抑制缺氧诱导因子足以抑制VHL-/-肿瘤的生长。
Mol Cancer Res. 2004 Feb;2(2):89-95.